1,720,985 research outputs found
Going Beyond Counting First Authors in Author Co-citation Analysis
Get PDFThe present study examines one of the fundamental aspects of author co-citation analysis (ACA) - the way co-citation
counts are defined. Co-citation counting provides the data on which all subsequent statistical analyses and mappings
are based, and we compare ACA results based on two different types of co-citation counting - the traditional type that
only counts the first one among a cited work's authors on the one hand and a non-traditional type that takes into
account the first 5 authors of a cited work on the other hand. Results indicate that the picture produced through this non-traditional author co-citation counting contains more coherent author groups and is therefore considerably clearer. However, this picture represents fewer specialties in the research field being studied than that produced through the traditional first-author co-citation counting when the same number of top-ranked authors is selected and analyzed. Reasons for these effects are discussed
Variations on the Author
Get PDF“Variations on the Author” discusses two of Eduardo Coutinho’s recent films (Um Dia na Vida, from 2010, and Últimas Conversas, posthumously released in 2015) and their contribution to the general question of documentary authorship. The director’s filmography is characterized by a consistent yet self-effacing form of authorial self-inscription: Coutinho often features as an interviewer that rather than express opinions propels discourses; an interviewer that is good at listening. This mode of self-inscription characterizes him as an author who is not expressive but who is nonetheless markedly present on the screen. In Um Dia na Vida, however, Coutinho is completely absent form the image, while Últimas Conversas, on the contrary, includes a confessional prologue that moves the director from the margins to the center of his films. This article examines the ways in which these works stand out in the filmography of a director who offers new insights into the notion of cinematic authorship
Appropriate Similarity Measures for Author Cocitation Analysis
Get PDFWe provide a number of new insights into the methodological discussion about author cocitation analysis. We first argue that the use of the Pearson correlation for measuring the similarity between authors’ cocitation profiles is not very satisfactory. We then discuss what kind of similarity measures may be used as an alternative to the Pearson correlation. We consider three similarity measures in particular. One is the well-known cosine. The other two similarity measures have not been used before in the bibliometric literature. Finally, we show by means of an example that our findings have a high practical relevance.information science;Pearson correlation;cosine;similarity measure;author cocitation analysis
Dispelling the Myths Behind First-author Citation Counts
Get PDFWe conducted a full-scale evaluative citation analysis study of scholars in the XML research field to explore just how different from each other author rankings resulting from different citation counting methods actually are, and to demonstrate the capability of emerging data and tools on the Web in supporting more realistic citation counting methods. Our results contest some common arguments for the continued
use of first-author citation counts in the evaluation of scholars, such as high correlations between author rankings by first-author citation counts and other citation
counting methods, and high costs of using more realistic citation counting methods that are not well-supported by the ISI databases. It is argued that increasingly available digital full text research papers make it possible for citation analysis studies to go beyond what the ISI databases have directly supported and to employ more
sophisticated methods
koamabayili/VECTRON-author-checklist: VECTRON author checklist
No full textWe have done our best to complete the author checklist relating to the use of animals in the hut study. Note that the objective for the hut study was to evaluate the IRS treatment applications for residual efficacy against Anopheles mosquitoes, including the local An. coluzzii mosquito population. Cows were only used to attract mosquitoes into the huts and no tests were carried out directly on the cows. The author checklist is intended for use with studies where experiments are carried out on animals, which is why we have had such difficulty in completing this for the hut study, as many of the questions do not relate to how the cows were used
Mechanisms underlying the Transformation of NPCs in PDGFA and Relevance to Human GBM
No full textThe lethal brain cancer, Glioblastoma (GBM), has a distinctive genomic architecture, but no known cause, modifiable risk factor, or curative treatment. Furthermore, our understanding of GBM is limited by our inability to appreciate how it begins by analyzing human tumor tissue and by the absence of authentic laboratory models of this cancer. Here, we decipher a mouse model of GBM developed in our laboratory to determine how exposure to Platelet-Derived Growth Factor-AA (PDGFA), a brain-abundant mitogen, transforms neural progenitor cells (NPCs), a putative GBM cell-of-origin. In our model, P53 null NPCs from the subventricular zone (SVZ) of young adult mice divide abnormally with widespread cell death. Surviving cells with chromosome instability become tumorigenic with a GBM-like genome. We show that PDGFA fails to induce the transcription of FoxM1 leading to incomplete expression of the kinetochore while simultaneously activating FOS and forcing mitotic errors. Defective mitosis together with impaired mitotic surveillance, as seen in P53 null cells, allows NPCs to survive with chromosome instability (CIN). Thereafter, survivors spontaneously resume dividing, accumulating chromosomal rearrangements, a change in phenotype accompanied by over-expression and phosphorylation of EGFR, increasing expression of Jun, re-expression of FoxM1 and the kinetochore, and return of FOS to basal levels, all in the presence of PDGFA. These adaptations allow NPCs with CIN to complete mitosis, proliferate, and achieve growth factor independence, and can be prevented by knockout of Fos and/or early inhibition of EGFR. By stimulating their proliferation without setting the stage for error-free mitosis, PDGFA transforms P53 null NPCs and generates Egfr amplified GBM-like cancer cells. To examine the potential relevance of our model to human GBM, we examine activation of PDGFA/PDGFRα signaling in the ageing mammalian brain and the integrity of the P53 pathway in GBM. We find lower expression of FoxM1 and a trend to higher expression of Pdgfrα in the ageing brain and show that a P53 null gene signature derived from murine cells clusters human astrocytic gliomas into IDH wild type and mutant groups. These findings encourage further exploration of our model as a segue to understanding the origins of GBM
Polo-like kinase-1 (PLK-1) inhibitors as novel therapeutics in oral squamous cell carcinoma
No full textPolo-like kinase-1 (PLK-1) belongs to a family of conserved serine/threonine kinases and is an oncogenic protein in many cancers. Therefore, PLK-1 is an attractive therapeutic target and clinical trials are ongoing to test the efficacy of PLK-1 inhibitors in several cancer-types. Oral squamous cell carcinoma (OSCC) is a common head and neck cancer. OSCC is associated with frequent recurrences after initial curative therapy and overall poor prognosis. We analysed RNA sequencing data from The Cancer Genome Atlas (TCGA) and found that PLK-1 mRNA levels are elevated in OSCC compared to normal oral cavity squamous epithelium and high PLK-1 expression in OSCC is associated with worse survival. Based on these results, we tested the efficacy of PLK-1 inhibitors in a panel of ten OSCC cell lines. The PLK-1 inhibitor, volasertib effected cell death at low nanomolar concentrations in most tested OSCC cell lines but not in normal oral keratinocytes. Flowcytometry analysis showed that volasertib induces G2/M arrest in sensitive cell lines. Western blot analysis showed that levels of total PLK-1 and phospho PLK-1 were reduced after volasertib treatment in sensitive cell lines. Volasertib also triggered apoptosis confirmed by the cleavage of PARP and Caspase 3. Cell lines resistant to volasertib did not show any alteration in total PLK-1 and pPLK-1 after volasertib treatment. Post-operative radiotherapy is a common treatment modality in OSCC patients. In two OSCC cell lines that were refractory to volasertib treatment, a combination of volasertib and γ-radiation significantly lowered cell survival compared to volasertib or γ-radiation alone. Combination therapy with γ-radiation and volasertib in resistant cell lines resulted in S-phase arrest. Western blot analysis showed a significant reduction of total PLK-1 and pPLK-1 after combinatorial therapy. Apoptosis was induced in volasertib resistant cells as a result of combination therapy. Taken together, these in vitro studies establish the rationale for further investigation of volasertib efficacy in orthotopic OSCC xenograft models and clinical trials
- …
